Drug Topics
JANUARY 13, 2023
A trio of leading hepatitis researchers survey the treatments in development for chronic hepatitis B. They end on a high note: That for the first time in 20 years, a cure is in sight.
STAT
JANUARY 13, 2023
Oscar Health has excelled at one thing in particular since its inception a decade ago: burning cash. The health insurance company did not plan to be profitable immediately. It was staking its future on the new Affordable Care Act marketplaces and had to grow quickly to compete with larger insurance carriers. Oscar organized its health insurance product through an app, promoted virtual care, advertised on New York subways, and then low-balled prices in certain markets to attract young, healthy pe
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 13, 2023
Recommendations were made for patients to help relieve inflammation, itching and infections.
Drug Store News
JANUARY 13, 2023
Retail pharmacy’s foray into clinical trial services is a no-brainer given their enhanced focus on improving patient outcomes in the communities they serve.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JANUARY 13, 2023
Health Canada has granted approval to Enhertu (trastuzumab deruxtecan) to treat unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer. Enhertu has been approved to treat HER2-low breast cancer adult patients who have previously received at least one line of chemotherapy in the metastatic setting or who have seen disease recurrence during or within six months after the adjuvant chemotherapy.
Pharmacy Times
JANUARY 13, 2023
Jordan Sloshower, MD, MSc, explains his experience working in several clinical trials investigating psilocybin-assisted therapy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JANUARY 13, 2023
Joseph Araujo, Chief Scientific Officer at Mindset Pharma, sat down to discuss natural vs. synthetic psychedelics.
Fierce Healthcare
JANUARY 13, 2023
Large healthcare bankruptcies rose 84% in 2022, though hospitals mostly dodged the bullet. dmuoio. Fri, 01/13/2023 - 14:00.
Pharmacy Times
JANUARY 13, 2023
Analysis focuses on causal effects while accounting for other environmental and genetic factors, such as a family history and socioeconomic disadvantages.
pharmaphorum
JANUARY 13, 2023
The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products. The lawsuit also takes aim at the three largest pharmacy benefit managers (PBMs) in the US – CVS Caremark, Express Scripts, and OptumRx – which are accused of adopting a system of rebates that incentivise manufacturers to raise list prices for insulin and promote higher-priced products.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JANUARY 13, 2023
Risk is highest for those who are obese or who have diabetes, investigator from Keck Medicine and the University of Southern California indicate.
STAT
JANUARY 13, 2023
SAN FRANCISCO — Ginkgo Bioworks CEO Jason Kelly is here trying to convince the world’s largest drugmakers that yes, really, he actually can in fact help you. Kelly’s powers of persuasion, so potent for so long, have often come up short since Ginkgo went public in 2021. The company that raised $1.6 billion privately on the promise of engineering cells to make everyday products like perfumes and synthetic burgers — even one day an iPhone — has sunk like a rock on
Pharmacy Times
JANUARY 13, 2023
“It's an honor to walk the last steps with someone, it is.”-Mary Lynn McPherson, PharmD, MA, MDE, FAAHPM.
STAT
JANUARY 13, 2023
WASHINGTON — David Kessler, the D.C. veteran who guided government dispatches of millions of Covid-19 vaccines and treatments, is exiting the Biden administration this month. His departure comes as the White House winds down a nearly three-year public health emergency amid stabilizing case trends, but also continues to grapple with depleted coronavirus response funds and public fatigue around the virus.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 13, 2023
Pharmacies should ensure appropriate monitoring procedures are in place to prevent contamination and exposure.
STAT
JANUARY 13, 2023
Access to treatment for addiction has long plagued U.S. health systems. Why? Two reasons: It is expensive, and the long-term value of addiction treatment is often disregarded by insurance companies and other payers. Its dirty little secret is that access to treatments that work are available to the few who can pay for it — as I once needed to do — while millions of Americans get substandard treatment or none at all.
Pharmacy Times
JANUARY 13, 2023
Analysis indicates that for individuals older than aged 40 years, the risk is cumulative and greatest 1 to 2 years after use.
STAT
JANUARY 13, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to promenade extensively with the official mascot, catch up on our reading, and maybe hold a listening party with Mrs. Pharmalot (for now, the rotation will start with this and this ).
Pharmacy Times
JANUARY 13, 2023
Zahra Mahmoudjafari, PharmD, BCOP, DPLA, opens a discussion surrounding chronic lymphocytic leukemia (CLL).
STAT
JANUARY 13, 2023
Editor’s note: A live stream of the event will be embedded below at 1 p.m. ET. Relive the return to an in-person J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for next week.
Drug Store News
JANUARY 13, 2023
For the month of December, HRG reviewed 39 products in the health category, 90 in the wellness sector and 137 items in the beauty category to see which ones stood out as Products to Watch.
STAT
JANUARY 13, 2023
Marianne De Backer’s iPhone calendar is a solid block of green. De Backer, the head of strategy and business development at Bayer, has so many meetings on her schedule that there’s no telling where one ends and another begins. She hasn’t moved for much of the day from her spot in a Hilton conference room in San Francisco, decorated in shades of tan.
pharmaphorum
JANUARY 13, 2023
Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres, hotel rooms, and rain-soaked Lyfts of San Francisco. After my customary cross-country redeye, I’ve officially traded the relentless rain of San Francisco for the gentle snowfall of my native Boston. And as I look out the window at that snow, my travel-addled brain can’t help but see it as a metaphor for pharma in 2023: a crisp white, wide canvas laden with possibilities, but also one that
The Checkup by Singlecare
JANUARY 13, 2023
Alcohol can interact with many antibiotics, which can sometimes lead to serious side effects. However, some antibiotics, such as clindamycin, may be safer than others when mixed with alcohol. It’s unlikely that you’ll experience any severe problems while mixing clindamycin and alcohol, as long as you’re drinking in moderation. . According to the drug’s FDA label , there is no known clindamycin and alcohol interaction.
STAT
JANUARY 13, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharmacy Times
JANUARY 13, 2023
Counseling sessions offer opportunity to educate about appropriate dosing, potential adverse effects.
Fierce Healthcare
JANUARY 13, 2023
JPM23's Health Tech Tidbits: Talkspace plots path to profitability, Veradigm invests in analytics company and Babylon CEO pushes back. hlandi. Fri, 01/13/2023 - 22:10.
STAT
JANUARY 13, 2023
SAN FRANCISCO — Carbon Health is in a turbulent time: The primary care tech company has had two recent rounds of layoffs and announced plans to dial back major business lines. Yet it still managed to score $100 million in new funding from CVS Health Ventures and launched a new, high-tech primary care partnership with Blue Cross Blue Shield of Massachusetts.
European Pharmaceutical Review
JANUARY 13, 2023
The European Pharmacopoeia (Ph. Eur.) Commission (EPC) adopted the revised general monographs 2034 and 2619 , at its 174th session in November 2022 , which now includes a paragraph explaining the Ph. Eur. approach to the control of N -nitrosamine impurities. A paragraph on N -nitrosamines has been added to Substances for pharmaceutical use (2034) under ‘Production’: “ N -Nitrosamines.
Drug Topics
JANUARY 13, 2023
Your weekly roundup of the latest news from Drug Topics®.
Fierce Healthcare
JANUARY 13, 2023
Following rapid expansion, Jefferson Health launches reorganization and, reportedly, layoffs. dmuoio. Fri, 01/13/2023 - 16:51.
Pharmacy Times
JANUARY 13, 2023
Developments may soon impact clinical practice in hematology and oncology.
Fierce Healthcare
JANUARY 13, 2023
Optum expects to treat 4M in fully accountable, value-based models this year. pminemyer. Fri, 01/13/2023 - 07:31.
Drug Store News
JANUARY 13, 2023
Scotch Porter has been identified by IRI as the fastest growing male grooming brand within the U.S. beard and hair care market.
Expert insights. Personalized for you.
186 
Let's personalize your content